Suicidal tendency associated with Levetiracetam: a systematic review
DOI:
https://doi.org/10.56294/piii2024347Keywords:
Levetiracetam, anticonvulsants, suicide, suicidal ideation, epilepsyAbstract
Background Suicidal behavior associated with the antiepileptic drug levetiracetam increases the risk of suicidal thoughts or tendencies, these patients should be monitored to detect the appearance or worsening of factors such as depression, suicidal ideation or unusual changes in behavior Objectives: To put at risk. day the information available in the medical literature about the little-known adverse effect of suicidal ideation or tendency due to the drug levetiracetam. Material and methods: In the present study, a
systematic review of the literature was carried out, in which the data of the studies published, from the year 2000 to the present date, were analyzed in the context of the topic investigated. Results Once the articles have been selected after application of inclusion and exclusion criteria, 21 were selected in this way that were useful to carry out this research, finding that suicidal tendency is related to the use of the drug Levetiracetam as antiepileptic treatmennt.
conclusion After examining the existing studies, the causal relationship of levetiracetam on suicidality in patients suffering from epilepsy is observed
References
Mula M, Bell GS, Sander JW. Suicidality in Epilepsy and Possible Effects of Antiepileptic Drugs. Curr Neurol Neurosci Rep. julio de 2010;10(4):327-32.
Lee JJ, Song HS, Hwang YH, Lee HW, Suh CK, Park SP. Psychiatric Symptoms and Quality of Life in Patients with Drug-Refractory
Epilepsy Receiving Adjunctive Levetiracetam Therapy. J Clin Neurol Seoul Korea. septiembre de 2011;7(3):128-36.
Koubeissi MZ. Monotherapy in Newly Diagnosed Epilepsy: Levetiracetam Versus Standard Anticonvulsants. Epilepsy Curr. 2014;14(5):255-6.
Knake S, Gruener J, Hattemer K, Klein KM, Bauer S, Oertel WH, et al. Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. J Neurol Neurosurg Psychiatry. mayo de 2008;79(5):588-9.
Mula M, Agrawal N, Mustafa Z, Mohanalingham K, Cock HR, Lozsadi DA, et al. Self-reported aggressiveness during treatment with levetiracetam correlates with depression. Epilepsy Behav. 1 de abril de 2015;45:64-7.
Bruton - Las bases farmacologicas de la Terapeutica.pdf [Internet]. [citado 30 de octubre de 2023]. Disponible en: https://oncouasd.files.wordpress.com/2015/06/goodmanfarmacologia.pdf
Brigo F, Bragazzi N, Nardone R, Trinka E. Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus. Epilepsy Behav EB. noviembre de 2016;64(Pt A):110-5.
Patsalos PN. Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet. 2004;43(11):707-24.
Minicucci F, Ferlisi M, Brigo F, Mecarelli O, Meletti S, Aguglia U, et al. Management of status epilepticus in adults. Position paper of the Italian League against Epilepsy. Epilepsy Behav. enero de 2020;102:106675.
Li Z ran, Wang C yu, Zhu X, Jiao Z. Population Pharmacokinetics of Levetiracetam: A Systematic Review. Clin Pharmacokinet. marzo de 2021;60(3):305-18.
Mbizvo GK, Chandrasekar B, Nevitt SJ, Dixon P, Hutton JL, Marson AG. Levetiracetam add‐on for drug‐resistant focal epilepsy. Cochrane Database Syst Rev. 30 de junio de 2020;2020(6):CD001901.
Park SP, Song HS, Hwang YH, Lee HW, Suh CK, Kwon SH. Differential effects of seizure control and affective symptoms on quality of life in people with epilepsy. Epilepsy Behav. agosto de 2010;18(4):455-9.
Mula M, Trimble MR, Sander JW. Are Psychiatric Adverse Events of Antiepileptic Drugs a Unique Entity? A Study on Topiramate and Levetiracetam. Epilepsia. 2007;48(12):2322-6.
Helmstaedter C, Fritz NE, Kockelmann E, Kosanetzky N, Elger CE. Positive and negative psychotropic effects of levetiracetam. Epilepsy Behav. octubre de 2008;13(3):535-41.
Rafnsson V, Ólafsson E, Hauser WA, Gudmundsson G. CauseSpecific Mortality in Adults with Unprovoked Seizures. Neuroepidemiology. 2001;20(4):232-6.
Fazel S, Wolf A, Långström N, Newton CR, Lichtenstein P. Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study. Lancet. 16 de noviembre de 2013;382(9905):1646-54.
Mula M, Sander JW. Suicidal ideation in epilepsy and levetiracetam therapy. Epilepsy Behav. agosto de 2007;11(1):130-2.
Lin M, Chen J, Li S, Qin Y, Wang X, Liu Y, et al. Risk factors for suicidal tendency in people with epilepsy in China: a case–control study. Sci Rep. 2 de febrero de 2021;11:2742.
Park SJ, Lee HB, Ahn MH, Park S, Choi EJ, Lee HJ, et al. Identifying clinical correlates for suicide among epilepsy patients in South Korea: A case–control study. Epilepsia. 2015;56(12):1966-72.
Bektaş G, Tekin U, Özkan MU, Yıldız EP, Çalışkan M, Özmen M, et al. The influence of levetiracetam on psychosocial and behavioral functioning in children: A casecontrol and follow-up study. Epilepsy Behav EB. julio de 2017;72:39-42.
Schneebaum-Sender N, Goldberg-Stern H, Fattal-Valevski A, Kramer U. Does a normalizing electroencephalogram in benign childhood epilepsy with centrotemporal spikes abort attention deficit hyperactivity disorder? Pediatr Neurol. octubre de 2012;47(4):279-83.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Daniel Alberto Polo Restrepo, Marcelo Adrián Estrin (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
